Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. - Wikidata - awgldk - TriplyDB

Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study.

Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study.

http://www.wikidata.org/entity/Q37310198

about

At risk for schizophrenic or affective psychoses? A meta-analysis of DSM/ICD diagnostic outcomes in individuals at high clinical risk Developmental mechanisms in the prodrome to psychosis Predicting the risk of psychosis onset: advances and prospects White matter development in the early stages of psychosis.Prophylactic valproic acid treatment prevents schizophrenia-related behaviour in Disc1-L100P mutant mice Schizophrenia, "Just the Facts" 6. Moving ahead with the schizophrenia concept: from the elephant to the mouse White matter microstructure in individuals at clinical high risk of psychosis: a whole-brain diffusion tensor imaging study Prediction and prevention of schizophrenia: what has been achieved and where to go next?Self-experience in the early phases of schizophrenia: 5-year follow-up of the Copenhagen Prodromal Study.Psychotropic medication use in youth at high risk for psychosis: comparison of baseline data from two research cohorts 1998-2005 and 2008-2011 Co-morbidity of personality disorder in schizophrenia among psychiatric outpatients in China: data from epidemiologic survey in a clinical population.Glycine treatment of the risk syndrome for psychosis: report of two pilot studies A critique of the "ultra-high risk" and "transition" paradigm.Prevalence of attenuated psychotic symptoms and their relationship with DSM-IV diagnoses in a general psychiatric outpatient clinic.Sexual dimorphisms and prediction of conversion in the NAPLS psychosis prodrome Prodromal symptoms in adolescents with 22q11.2 deletion syndrome and schizotypal personality disorder.Schizophrenia: an integrated sociodevelopmental-cognitive model.Self-reported cannabis use is inconsistent with the results from drug-screening in youth at ultra high-risk for psychosis in Colorado Potential stigma associated with inclusion of the psychosis risk syndrome in the DSM-V: an empirical question The psychosis risk syndrome and its proposed inclusion in the DSM-V: a risk-benefit analysis.Current status specifiers for patients at clinical high risk for psychosis.Subthreshold psychotic symptoms in 22q11.2 deletion syndrome.The 2nd Schizophrenia International Research Society Conference, 10-14 April 2010, Florence, Italy: summaries of oral sessions.Prevalence and clinical significance of DSM-5-attenuated psychosis syndrome in adolescents and young adults in the general population: the Bern Epidemiological At-Risk (BEAR) study.Ultra high risk of psychosis on committal to a young offender prison: an unrecognised opportunity for early intervention.The reliability and validity of the korean version of the structured interview for prodromal syndrome.Are screening instruments valid for psychotic-like experiences? A validation study of screening questions for psychotic-like experiences using in-depth clinical interview.The case for including Attenuated Psychotic Symptoms Syndrome in DSM-5 as a psychosis risk syndrome.Attenuated psychosis and the schizophrenia prodrome: current status of risk identification and psychosis prevention "Attenuated psychotic symptoms syndrome" as a risk syndrome of psychosis, diagnosis in DSM-V: The debate Testing measurement invariance of the schizotypal personality questionnaire-brief scores across Spanish and Swiss adolescents.Towards a psychosis risk blood diagnostic for persons experiencing high-risk symptoms: preliminary results from the NAPLS project.Does a parent-report measure of behavioral problems enhance prediction of conversion to psychosis in clinical high-risk adolescents?At clinical high risk for psychosis: outcome for nonconverters.Premorbid functional development and conversion to psychosis in clinical high-risk youths.Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of ps Negative symptoms and impaired social functioning predict later psychosis in Latino youth at clinical high risk in the North American prodromal longitudinal studies consortium.Prodromal Symptom Severity Predicts Accelerated Gray Matter Reduction and Third Ventricle Expansion Among Clinically High Risk Youth Developing Psychotic Disorders Prodromal psychosis detection in a counseling center population in China: an epidemiological and clinical study.A survey of psychosis risk symptoms in Kenya.

P2860

Q27002449-83BA9C34-2023-44D0-B2BA-D991BCE50541 Q27009237-97F8159A-1BBC-43D2-BA77-95572E4CB0CF Q27011694-BD064C7E-A0AD-4198-9D88-65FF922F53E7 Q27686764-D77FBD89-B54B-44D2-B061-39AFF8D92B5D Q28484428-2C81BC47-54AE-4BAA-AC28-9F28997D478E Q28727394-784CDE80-9135-4B5F-9692-4D916BA69D13 Q30408071-AD32BD48-F377-45E0-9E88-A3067BB4AE1F Q30473765-8F1F7BAC-5F2C-401A-8701-E31AB78F63C6 Q30473766-EFC9B8A4-8291-4F51-8F70-58FC11D2B95C Q30650589-985720B5-7970-4FA0-8464-D66CC8D63DB6 Q31113399-DC936523-9A81-4CC2-97C8-CD7535E9E252 Q33637911-9D1905B9-979E-4389-A5EB-E1B25A9159D6 Q33670654-F9F52505-C8BC-4862-8D0C-25C2E57118E6 Q33677429-8C1E1F25-4978-4691-A0D5-37FF0B0D8EF5 Q33711020-884EF832-7D83-4E79-BE79-E2459018B714 Q33878153-A873D01C-5D84-4DC0-BE1C-A9BAEB048468 Q34023115-6C8B5822-8206-40B5-9ABF-7A18644015FD Q34051836-8C051062-6253-4C1C-9452-8A537A18F5AC Q34064802-A46D1823-3408-4361-8AB9-C99DA84763A6 Q34071212-E54A815C-0DEC-4D57-A16F-D1867AD3B44D Q34123531-BF1A37F9-4E10-431A-B458-CC10517F07A7 Q34156406-2F05C105-EEBD-45EA-8421-C5D70314E8E2 Q34279073-EDF3F7F0-EC74-4949-89B0-038FA910824B Q34322905-140713A0-C252-4A67-B787-47010ACE10F1 Q34365907-7743751E-6FD5-46E0-8B28-0EFBEAC11808 Q34497547-4C1D400F-0EFA-410F-BB3D-0FDFEC39A249 Q34604254-1DBA188C-1A02-4EF9-850C-70FFDF845A68 Q34623331-A2772088-3D14-4B2A-AE56-D4FE48F61FA9 Q34644978-81C5875D-BBA4-4B94-B9E8-1F558BC020A0 Q34664735-DC7947EB-0404-4934-8855-3A13EC4D5741 Q35069936-CFDC72F0-ABF5-4324-8403-1732F168A0D7 Q35096541-D9E428EA-9959-408D-AFC7-902A2AC20A87 Q35115886-4C220A52-3372-4947-AC51-D513CC478F70 Q35148454-5741C3EF-7F33-4E5F-BD6F-2CCB872A1BC4 Q35168098-7089AA14-2DD4-4C04-84FD-E8E3B12BBF78 Q35176725-0613BEE2-B63E-47D7-B8F5-5DBAC200F008 Q35185253-DB1C9331-3E21-4B93-93CB-1BA2D51B8E2F Q35621468-A2114BF3-DCFA-44FB-BD2F-47FDF3F2FB04 Q35639344-8B70038A-D312-4C11-A192-34698ED95C5F Q35693423-EE35D75D-3820-479F-A647-37997A8E1F82

P2860

Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study.

http://www.wikidata.org/entity/Q37310198

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 April 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Validity of the prodromal risk ...... n Prodrome Longitudinal Study.

@en

Validity of the prodromal risk ...... n Prodrome Longitudinal Study.

@nl

type

label

Validity of the prodromal risk ...... n Prodrome Longitudinal Study.

@en

Validity of the prodromal risk ...... n Prodrome Longitudinal Study.

@nl

prefLabel

Validity of the prodromal risk ...... n Prodrome Longitudinal Study.

@en

Validity of the prodromal risk ...... n Prodrome Longitudinal Study.

@nl

P1433

Q37310198-BD0502E0-8269-41AF-9E39-B917BD10A861

P1476

Q37310198-A9B22BFB-618F-4D2E-B7BB-BC3782EBC302

P2093

Q37310198-2C9EF708-ADF1-4B10-A2AE-1F0EA323A208

Q37310198-96417536-B5DE-4530-83CC-2E3343B8CB57

Q37310198-C0B2636D-7DE1-4CFB-A3A3-96BE47A78AED

Q37310198-C5FE9E53-3AA3-4BAD-93B2-82C32938C7A3

Q37310198-D5D7001A-3B87-42C8-9F11-8F1DC58E7974

Q37310198-E2D244B2-00A4-48F8-83F9-0B684EA7065D

P2860

Q37310198-073F3CB1-59F5-4EFE-8147-8FF1BDC87403

Q37310198-0C4C9CC8-33AC-42B2-A546-2B3AD4001AF8

Q37310198-0F642A63-0700-4D12-BC58-1E43B4E9094B

Q37310198-10C1D05D-9C2F-401E-9FDB-8F1710860E52

Q37310198-1360A08F-8B30-4F92-8C32-EDF30DE0B48A

Q37310198-13B736DA-0FD0-42C8-A03C-0F5D2A8AF165

Q37310198-1592B043-E19A-4892-BFC0-A632D5ECC824

Q37310198-169E1FE0-CE0C-4451-827F-5D8302DF4668

Q37310198-1DE056F7-CDBC-40F5-B843-B678574E4257

Q37310198-22FE4355-507F-4F69-826F-714FA0028AB5

P304

Q37310198-C33A4202-7C1F-4A09-9AC3-F7E9EBBE1848

P31

Q37310198-A6EFE608-82FF-4B27-8D9F-C5ECDF800F43

P356

Q37310198-1BBEEDB5-8C22-42E6-B385-BE833201B58A

P407

Q37310198-18684CD6-9842-4E88-9717-7BDA26771B20

P433

Q37310198-8A26C3C6-28D6-4EE8-AEE6-9D5B5204970D

P478

Q37310198-9EE698E2-E487-4D37-8127-E4570F72B415

P50

Q37310198-123DAA7A-7011-49C2-93BD-8A74D73CB045

Q37310198-625DEB62-1CAF-4787-8D68-0776F348689B

Q37310198-7D2EB9E7-394D-446A-B46D-FD58AB2D6CA5

Q37310198-A400594C-48EB-44BE-AA7D-EFCE674787CC

Q37310198-A847337D-4B11-40AE-97C7-17341A00E7D9

P577

Q37310198-7E9BADEA-347C-433B-BD9E-24C904EF197E

P5875

Q37310198-A33457E0-0137-4CC6-8AE7-00F5C73B8144

P698

Q37310198-356F710A-3593-43F3-9E41-8D5460738E71

P921

Q37310198-B8F678B9-696F-4A24-88F4-CD05DDD90826

P932

Q37310198-B57E32F8-15D8-4C26-8BDF-EAB45A281575

P356

P1433

Schizophrenia Bulletin

P1476

Validity of the prodromal risk ...... n Prodrome Longitudinal Study.

@en

P2093

Barbara A Cornblatt

http://www.w3.org/2001/XMLSchema#string

Diana O Perkins

http://www.w3.org/2001/XMLSchema#string

Elaine F Walker

http://www.w3.org/2001/XMLSchema#string

Ming T Tsuang

http://www.w3.org/2001/XMLSchema#string

Robert Heinssen

http://www.w3.org/2001/XMLSchema#string

Scott W Woods

http://www.w3.org/2001/XMLSchema#string

P2860

North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research

Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis

Monitoring and care of young people at incipient risk of psychosis

Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data

The prevalence and correlates of nonaffective psychosis in the National Comorbidity Survey Replication (NCS-R)

Diagnosing schizophrenia in the initial prodromal phase.

Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia.

Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability.

Global assessment of functioning. A modified scale.

Treatment of the schizophrenia prodrome: is it presently ethical?

P304

894-908

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/SCHBUL/SBP027

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P50

Thomas McGlashan

Kristin S Cadenhead

Larry J Seidman

P577

2009-04-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24349906

http://www.w3.org/2001/XMLSchema#string

P698

19386578

http://www.w3.org/2001/XMLSchema#string

P921

P932

2728816

http://www.w3.org/2001/XMLSchema#string